103.67
Finanzdaten der Exact Sciences Corp-Aktie (EXAS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
3.25%
878.38
|
850.74 | 811.09 | 706.78 | 708.65 |
| Cost Of Revenue |
1.59%
262.56
|
266.81 | 248.63 | 206.24 | 196.07 |
| Gross Profit |
5.46%
615.83
|
583.93 | 562.45 | 500.55 | 512.59 |
|
|
14.59%
698.42
|
609.47 | 564.60 | 596.56 | 551.99 |
| Benefits Costs and Expenses |
10.93%
963.46
|
868.50 | 811.14 | 807.78 | 746.08 |
| Costs And Expenses |
10.93%
963.46
|
868.50 | 811.14 | 807.78 | 751.16 |
| Operating Income/Loss |
223.33%
-82.59
|
-25.55 | -2.148 | -96.01 | -39.40 |
| Nonoperating Income/Loss |
131.95%
-2.488
|
7.788 | 2.091 | -4.981 | 1.975 |
| Income/Loss From Continuing Operations Before Tax |
379.15%
-85.08
|
-17.76 | -0.057 | -100.99 | -37.43 |
| Income Tax Expense/Benefit, Deferred |
305.99%
-1.032
|
0.501 | -0.006 | -1.007 | -0.398 |
| Income Tax Expense/Benefit |
52.53%
0.872
|
1.837 | 1.128 | 0.224 | 0.808 |
| Income/Loss From Continuing Operations After Tax |
338.68%
-85.95
|
-19.59 | -1.185 | -101.22 | -38.24 |
|
|
338.68%
-85.95
|
-19.59 | -1.185 | -101.22 | -38.24 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.81%
0.353
|
189.26 | 188.90 | 186.81 | 184.79 |
| Diluted Average Shares |
99.81%
0.353
|
189.26 | 188.90 | 186.81 | 184.79 |
| Basic Earnings Per Share |
350.00%
-0.45
|
-0.10 | -0.01 | -0.54 | -0.21 |
| Diluted Earnings Per Share |
350.00%
-0.45
|
-0.10 | -0.01 | -0.54 | -0.21 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):